IPO's
Expected gross proceeds before fees
USD million; public amount rounded
Sources: [1] Windward Bio: pricing announcement filed under Rule 433 · 2026-11-12; closing expected November 16, after cutoff
Windward Prices Its IPO Alongside a Private Placement
A clinical-stage biotechnology offering illustrates why the public share sale, strategic financing and closing timetable must be read separately.
Sources: Windward Bio: pricing announcement filed under Rule 433; SEC Investor.gov: Updated Investor Bulletin, Investing in an IPO
Read the report →